# Hua Medicine Limited

Organization · id `cardio:org-hua-medicine-limited` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov sponsor names](<https://clinicaltrials.gov/search?spons=Hua+Medicine+Limited>), retrieved 18 November 2026. No person wrote or checked this page.

## In plain language

An organization that ClinicalTrials.gov lists as a sponsor or collaborator of 3 trials in this atlas.

## Technical summary

Sponsor class industry. No ROR record matches the name exactly.

## The registry's words

- Sponsor name: Hua Medicine Limited
- Sponsor class: INDUSTRY

## Connected pages

- Sponsors: A Multi-center 12-week Study of HMS5552 in T2DM (`cardio:ct-nct02561338`)
- Sponsors: Long-term Efficacy and Safety of HMS5552 add-on to Metformin in T2DM Subjects (`cardio:ct-nct03141073`)
- Sponsors: Long-term Efficacy and Safety of HMS5552 in T2DM Subjects (`cardio:ct-nct03173391`)

## Provenance

Content hash: 3fa99b4b56e2b9e9c172d2ae77c99ecf090bcff158b830e5b8166655133b0399
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
